LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells

L-type amino acid transporter 1 (LAT1, SLC7A5) incorporates essential amino acids into cells. Recent studies have shown that LAT1 is a predominant transporter in various human cancers. However, the function of LAT1 in thymic carcinoma remains unknown. Here we demonstrate that LAT1 is a critical tran...

Full description

Bibliographic Details
Main Authors: Keitaro Hayashi, Promsuk Jutabha, Sumiko Maeda, Yothaisong Supak, Motoshi Ouchi, Hitoshi Endou, Tomoe Fujita, Masayuki Chida, Naohiko Anzai
Format: Article
Language:English
Published: Elsevier 2016-11-01
Series:Journal of Pharmacological Sciences
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1347861316300883
_version_ 1818249753720258560
author Keitaro Hayashi
Promsuk Jutabha
Sumiko Maeda
Yothaisong Supak
Motoshi Ouchi
Hitoshi Endou
Tomoe Fujita
Masayuki Chida
Naohiko Anzai
author_facet Keitaro Hayashi
Promsuk Jutabha
Sumiko Maeda
Yothaisong Supak
Motoshi Ouchi
Hitoshi Endou
Tomoe Fujita
Masayuki Chida
Naohiko Anzai
author_sort Keitaro Hayashi
collection DOAJ
description L-type amino acid transporter 1 (LAT1, SLC7A5) incorporates essential amino acids into cells. Recent studies have shown that LAT1 is a predominant transporter in various human cancers. However, the function of LAT1 in thymic carcinoma remains unknown. Here we demonstrate that LAT1 is a critical transporter for human thymic carcinoma cells. LAT1 was strongly expressed in human thymic carcinoma tissues. LAT1-specific inhibitor significantly suppressed leucine uptake and growth of Ty82 human thymic carcinoma cell lines, suggesting that thymic carcinoma takes advantage of LAT1 as a quality transporter and that LAT1-specific inhibitor might be clinically beneficial in therapy for thymic carcinoma.
first_indexed 2024-12-12T15:41:30Z
format Article
id doaj.art-6058706be7b249baabd7f8730bb9aec4
institution Directory Open Access Journal
issn 1347-8613
language English
last_indexed 2024-12-12T15:41:30Z
publishDate 2016-11-01
publisher Elsevier
record_format Article
series Journal of Pharmacological Sciences
spelling doaj.art-6058706be7b249baabd7f8730bb9aec42022-12-22T00:19:53ZengElsevierJournal of Pharmacological Sciences1347-86132016-11-01132320120410.1016/j.jphs.2016.07.006LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cellsKeitaro Hayashi0Promsuk Jutabha1Sumiko Maeda2Yothaisong Supak3Motoshi Ouchi4Hitoshi Endou5Tomoe Fujita6Masayuki Chida7Naohiko Anzai8Department of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of General Thoracic Surgery, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanJ-Pharma Co., Ltd., Yokohama, Kanagawa 230-0046, JapanDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of General Thoracic Surgery, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Shimotsuga, Tochigi 321-0293, JapanL-type amino acid transporter 1 (LAT1, SLC7A5) incorporates essential amino acids into cells. Recent studies have shown that LAT1 is a predominant transporter in various human cancers. However, the function of LAT1 in thymic carcinoma remains unknown. Here we demonstrate that LAT1 is a critical transporter for human thymic carcinoma cells. LAT1 was strongly expressed in human thymic carcinoma tissues. LAT1-specific inhibitor significantly suppressed leucine uptake and growth of Ty82 human thymic carcinoma cell lines, suggesting that thymic carcinoma takes advantage of LAT1 as a quality transporter and that LAT1-specific inhibitor might be clinically beneficial in therapy for thymic carcinoma.http://www.sciencedirect.com/science/article/pii/S1347861316300883Thymic carcinomaAnticancer drugTransporter
spellingShingle Keitaro Hayashi
Promsuk Jutabha
Sumiko Maeda
Yothaisong Supak
Motoshi Ouchi
Hitoshi Endou
Tomoe Fujita
Masayuki Chida
Naohiko Anzai
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
Journal of Pharmacological Sciences
Thymic carcinoma
Anticancer drug
Transporter
title LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
title_full LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
title_fullStr LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
title_full_unstemmed LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
title_short LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
title_sort lat1 acts as a crucial transporter of amino acids in human thymic carcinoma cells
topic Thymic carcinoma
Anticancer drug
Transporter
url http://www.sciencedirect.com/science/article/pii/S1347861316300883
work_keys_str_mv AT keitarohayashi lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT promsukjutabha lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT sumikomaeda lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT yothaisongsupak lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT motoshiouchi lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT hitoshiendou lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT tomoefujita lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT masayukichida lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells
AT naohikoanzai lat1actsasacrucialtransporterofaminoacidsinhumanthymiccarcinomacells